Open AccessThe docetaxel debate: impact of chemotherapy in high-risk non-metastatic prostate cancer
Author(s) -
Mark Hurwitz
Publication year - 2019
Publication title -
translational andrology and urology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.721
H-Index - 27
eISSN - 2223-4691
pISSN - 2223-4683
DOI - 10.21037/tau.2019.06.09
Subject(s) - docetaxel , medicine , prostate cancer , oncology , prostatectomy , disease , chemotherapy , radiation therapy , androgen deprivation therapy , cancer